Raymond Wadlow

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pfizer
    Topic: 
    Colorectal cancer
    Date added: 
    05/20/2023
    Relationship end date: 
    03/28/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Seagen
    Topic: 
    Colorectal cancer
    Date added: 
    05/20/2023
    Relationship end date: 
    10/24/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Exact Sciences
    Topic: 
    Colorectal cancer
    Date added: 
    05/20/2023
    Relationship end date: 
    01/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Taiho
    Topic: 
    Colorectal cancer
    Date added: 
    05/20/2023
    Relationship end date: 
    03/30/2023
  • Attribution: 
    Spouse or Partner
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Johnson & Johnson
    Topic: 
    Lung cancer
    Date added: 
    05/20/2023
Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond